Effects of the sodium‐glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptanKen Ohara, Daisuke Nagata, Mari Okada et al.|Nephrology|2018Cited by 82
Association between circulating fibroblast growth factor 21 and mortality in end-stage renal diseaseMarina Kohara, Daisuke Nagata, Takahiro Masuda et al.|PLoS ONE|2017Cited by 66
Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid RetentionTakahiro Masuda, Daisuke Nagata, Takuya Murakami et al.|Internal Medicine|2016Cited by 26